Kaharu Sumino

Medicine & Life Sciences

1. Asthma 100%
2. Adrenal Cortex Hormones 25%
3. Metapneumovirus 22%
4. Methacholine Chloride 20%
5. African Americans 18%
6. Bronchial Thermoplasty 17%
7. Respiratory Syncytial Viruses 16%
8. Randomized Controlled Trials 15%
9. Vitamin D 14%
10. Placebos 14%
11. Nebulizers and Vaporizers 12%
12. Viruses 12%
13. DNA Vaccines 12%
14. Lung 11%
15. Medication Adherence 11%
16. Respiratory Tract Infections 10%
17. Inflammation 10%
18. lebrikizumab 10%
19. Bocavirus 9%
20. Reminder Systems 9%
21. benralizumab 9%
22. Chronic Obstructive Pulmonary Disease 8%
23. HIV-1 8%
24. saponin QA-21V1 8%
25. Orthomyxoviridae 8%
26. Virus Diseases 8%
27. Rhinovirus 8%
28. Infections 8%
29. Vaccination 8%
30. Mucosal Immunity 7%
31. Comparative Effectiveness Research 7%
32. Safety 7%
33. Antiviral Agents 7%
34. Esomeprazole 7%
35. Bronchodilator Agents 7%
36. Pragmatic Clinical Trials 7%
37. Child 7%
38. Therapeutics 6%
39. Alendronate 6%
40. Treatment Failure 6%
41. Cholecalciferol 6%
42. H1N1 Subtype Influenza A Virus 6%
43. Isoflavones 6%
44. Optic Nerve Diseases 6%
45. Bronchiolitis 6%
46. Patient Reported Outcome Measures 6%
47. Saponins 5%
48. Forced Expiratory Volume 5%
49. Interferons 5%
50. Influenza Vaccines 5%